300314.SZ
戴维医疗
SZSE · Healthcare · C 制造业 · CN
CNY 12.45
−5.03%Margins
Gross margin
52.2%
EBITDA margin
21.8%
EBIT margin
14.7%
Net margin
12.9%
FCF margin
7.3%
6.0%
Return on equity
5.1%
Return on assets
6.8%
Return on invested capital
0.39x
Asset turnover
CNY 84.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026